title: Epidemiology of Hepatitis C Virus: A Battle on New Frontiers.
abstract: The hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality in the United States and other parts of the world. The epidemiology of the disease is highly variable between and within countries, and strategies to deal with HCV identification and treatment must be tailored to the geographic location and the political and economic environment of the region. Although great strides have been made in improving HCV transmission risk in blood supply products, new challenges related to changing patterns of disease incidence continue to require fresh evaluation and new approaches to disease prevention.
authors.affiliation: Epidemiology, AstraZeneca Pharmaceuticals LLC, 1 MedImmune Way, Gaithersburg, MD 20878, USA. Electronic address: norah.shire@astrazeneca.com.
authors.forename: Norah J
authors.initials: NJ
authors.lastname: Shire
authors.affiliation: Division of Digestive Diseases, University of Cincinnati College of Medicine, University of Cincinnati, 231 Albert B Sabin Way, Cincinnati, OH 45267-0595, USA.
authors.forename: Kenneth E
authors.initials: KE
authors.lastname: Sherman
mesh_terms: D019049:Developed Countries; D003906:Developing Countries; D014943:Global Health; D019698:Hepatitis C, Chronic / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D015994:Incidence; D015995:Prevalence
keywords: Acute HCV; Co-infection; HCV epidemiology; Incidence; Prevalence